T-cell signal transduction and the role of protein kinase C

Cellular and Molecular Life Sciences

Volumn 54, Issue 10, 1998, Pages 1122-1144

  Wilkinson, S E ^a   Nixon, J S ^a  

^a Roche Discovery Welwyn ^*  (United Kingdom)

Author keywords

Protein kinase C; Signal transduction; T cell

Indexed keywords

PROTEIN KINASE C;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; HUMAN; LYMPHOCYTE PROLIFERATION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; HUMANS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0031751087     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050241     Document Type: Review

References (168)

1. Breedveld F. C. and Verweij C. L. (1997) T cells in rheumatoid arthritis. Br. J. Rheumatol. 36: 617-621
2. Hohlfield R., Londei M., Massacesi L. and Salvetti M. (1995) T-cell autoimmunity in multiple sclerosis. Immunol. Today 16: 259-261
3. Valdimarrson H., Baker B. S., Jonsdottir I., Powles A. and Fry L. (1995) Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal superantigens? Immunol. Today 16: 145-149
4. Sasny P. N. (1987) HLA and the role of T cell in the predisposition to disease. Rheum. Dis. Clin. North Am. 13: 1-6
5. Zanelli E., Gonzalez-Gay M. A. and David C. S. (1995) Could HLA-DRB1 he the protective locus in rheumatiod arthritis? Immunol. Today 16: 274-278
6. Meeusen E. N. T., Premier R. R. and Brandon M. R. (1996) Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells? Immunol. Today 17: 421-424
7. Carruthers D. M., Naylor W. G., Allen M. E., Kitas G. D., Bacon P. A. and Young S. P. (1996) Characterisation of altered calcium signalling in T lymphocytes from patients with rheumatoid arthritis. Clin. Exp. Immunol. 105: 291-296
8. Van Den Broek M., Boeije L., Swaak T., Smeenk R. and Aarden L. (1995) Functional analysis of synovial fluid and peripheral blood T cells from patients with rheumatoid arthritis. Rheumatol. Int. 15: 137-143
9. De Keyser F., Elewaut D., Vermeersch J., DeWever N., Cuvelier C. and Veys E. M. (1995) The role of T cells in rheumatoid arthritis. Clin. Rheumatol. 14 (Suppl. 2): 5-9
10. Miltenburg A. M. M., Lacraz S., Welgus H. G. and Dayer J-M. (1995) Immobilised anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J. Immunol. 154: 2655-2667
11. Ramanujam T., Luchi M., Schumacher H. R., Zwillich S., Chang C. P., Callegari P. E. et al. (1995) Detection of T cell receptors in early rheumatoid arthritis synovial tissue. Pathobiology 63: 100-108
12. Fischer D.-C., Opalka B., Hoffmann A., Mayr W. and Haubeck H.-D. (1996) Limited heterogeneity of rearranged T cell receptor V-alpha and V-beta transcripts in synovial fluid T cells in early stages of rheumatoid arthritis. Arthritis Rheum. 39: 454-462
13. Multiple Sclerosis Genetics Group. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat. Genet. 13: 469-471
14. Ikaheimo I., Tiilikainen A., Karvonen J. and Silvennoinen-Kassinen S. (1996) HLA risk haplotype Cw6,DR7,DQA 1*0201 and HLA-Cw6 with reference to the clinical picture of Psoriasis vulgaris. Arch. Dermatol. Res. 288: 363-365
15. Trembath R. C., Clough R. L., Rosbotham J. L., Jones A. B., Camp R. D. R., Frodsham A. et al. (1997) Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci by a two-Stage genome-wide search in psoriasis. Hum. Mol. Genet. 6: 813-820
16. Berger T., Weerth S., Kojima K., Linington C., Wekerle H. and Lassmann H. (1997) Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76: 355-364
17. Wrone-Smith T. and Nickoloff B. J. (1996) Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98: 1878-1887
18. + T-cell subsets characterised by co-expression of CD45RA and CD45R0 isoforms. Blood 88: 3513-3521
19. Hwang S. T., Singer M. M., Giblin P. A., Yednock T. A., Bacon K. B. and Simon S. I. (1996) GlyCAM-1, a physiological ligand for L-selectin, activates beta-2 integrins on naive peripheral lymphocytes. J. Exp. Med. 184: 1343-1348
20. + TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med. 182: 1505-1515
21. Kanegane H. and Tosato G. (1996) Activation of naive and memory T cells by interleukin-15. Blood 88: 230-235
22. Mossman T. R. and Sad S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17: 138-146
23. DiPiro J. T. (1997) Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection and sepsis. Pharmacotherapy 17: 205-223
24. Schultze-Koops H., Lipsky P. E., Kavanaugh A. F. and Davis L. S. (1995) Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J. Immunol. 155: 5029-5037
25. Dolhain R. J. E. M., Van der Heiden A. M., TerHaar N. T., Breedvald F. C. and Mittenburg A. M. M. (1996) Shift toward T-lymphocyte with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 39: 1961-1969
26. + T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 94: 599-603
27. DeJong R., Bezemer A. C., Zomerdijk T. P. L., Van der Poun-Kraan T., Ottenhof T. H. M. and Nibbering P. H. (1996) Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur. J. Immunol. 26: 2067-2074
28. + T cells in the pathogenesis of organ-specific autoimmune disease. Immunol. Today 16: 34-38
29. + in the pathogenesis of allergic diseases. Proc. Soc. Exp. Biol. Med. 215: 11-20
30. + T cells in asthma. Immunol. Cell Biol. 74: 206-208
31. +4 T helper cell phenotype development on a T cell receptor-α-β-transgenic model. J. Exp. Med. 182: 1579-1584
32. Hilkens C. M. V., Snijders A., Snijdement F. G. M., Wieranga E. A. and Kapsenberg M. L. (1996) Modulation of T-cell cytokine secretion by accessory cell-derived products. Eur. Respir. J. 9 (Suppl. 2): 905-945
33. + T cells, analysed at the single cell level. J. Exp. Med. 184: 413-483
34. + T cell subsets: Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro J. Immunol. 144: 1788
35. Maruo S., Toyo-oka K., Oh-hora M., Tai X.-G., Iwata H., Takenaka H. et al. (1996) IL-12 produced by antigen-presenting cells induces IL-2 independent proliferation of T-helper cell clones. J. Immunol. 140: 4211-4216
36. Umetsu D. T., Jabara H. H., DeKruyff R. H., Abbas A. K., Abrams J. S. and Geta R. S. (1988) Functional heterogeneity among human inducer T cell clones. J. Immunol. 140: 4211-4216
37. Kelso A. (1995) Th1 and Th2 subsets: paradigms lost? Immunol. Today 16: 374-379
38. Bradley L. M., Croft M. and Swain S. L. (1993) T cell memory: new perspectives. Immunol. Today 14: 197-199
39. Chiocchia D. A., Baldwin M. and Smith K. A. (1995) Memory T cells are hypersensitive and hyper-responsive compared with naive T cells. Ninth International Congress of Immunology meeting, San Francisco, CA, abstract 162
40. Cantrell D. A., Pastor M. I., Reif K. and Woodrow M. (1995) T cell activation in T cell receptors', pp. 151-163. Bell J. I., Owen M. J. and Simpson E. (eds). Oxford University Press, Oxford
41. Weiss A. (1993) T cell antigen receptor signalling transduction: a tale of tails and cytoplasmic protein kinases. Cell 73: 209-212
42. Kersh G. J. and Allen P. M. (1996) Structural basis of T cell recognition of altered peptide ligands. A single T cell receptor can productively recognise a large continuum of related ligands. J. Exp. Med. 184: 1525-1530
43. Sloan-Lancaster J., Steinberg T. H. and Allen P. M. (1996) Selective activation of the calcium signalling pathway by altered peptide ligands. J. Exp. Med. 184: 1525-1530
44. Racioppi L., Ronchese F., Matis L. A. and Germain R. A. (1993) Peptide-major histocompatability complex class II complexes with mixed agonist antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signalling. J. Exp. Med. 177: 1047-1060
45. Madrenas J., Chau L. A., Smith J., Bluestone J. A. and Germain R. N. (1997) The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist-partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185: 219-229
46. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 251: 1228-1231
47. Osman N., Turner H., Lucas S., Reif K. and Cantrell D. A. (1996) The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor zeta sub-units and the CD3 gamma, delta and epsilon chains. Eur. J. Immunol. 26: 1063-1068
48. Weiss A. and Littman D. R. (1994) Signal transduction by lymphocyte antigen receptor. Cell 76: 263-274
49. Klausner R. D. and Samelson L. E. (1991) T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell 64: 875-878
50. Strauss D. B., Chan A. C., Patai B. and Weiss A. (1996) SH2 domain function is essential for the role of lck tyrosine kinase in T cell receptor signal transduction J. Biol. Chem. 271: 9976-9981
51. Weil R., Cloutier J.-F., Fournei M. and Veilette A. (1995) Regulation of ZAP-70 by Src family tyrosine kinases in an antigen-specific T cell line. J. Biol. Chem. 270: 2791-2799
52. Madrenas J., Wange R. L., Wang J. L., Isakov N., Samelson L. E. and Germain R. N. (1995) ζ Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267: 515-518
53. + thymic selection in humans lacking ZAP-70 kinase. Cell 76: 947-958
54. Elder M. E., Lin D., Clever J., Chan A.-C., Hope T. J., Weiss A. et al. (1994) Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell Tyrosine kinase. Science 264: 1596-1599
55. Qian D., Mollenauer M. N. and Weiss A. (1996) Dominant negative receptor signalling. J. Exp. Med. 183: 611-620
56. Zhao Q. and Weiss A. (1996) Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70. Mol. Cell Biol. 16: 6765-6774
57. Wu. J., Motto D. G., Koretsky G. A. and Weiss A. (1996) A complex between p95-vav and SLP-76 is induced in TCR-mediated IL-2 gene induction. FASEB J. 10: A1027
58. Wardenburg J. B., Fu C., Jackman J. K., Flotow H., Wilkinson S. E., Williams D. H. et al. (1996) Phosphorylation of SLP-76 by ZAP-70 protein tyrosine kinase as required for T-cell receptor function. J. Biol. Chem. 271: 19641-19644
59. Huby R. D. J., Carlisle G. W. and Ley S. C. (1995) Interactions between the protein-tyrosine kinase ZAP-70, the protooncoprotein Vav and tubulin in Jurkat T cells. J. Biol. Chem. 270: 30241-30244
60. Uddin S., Sweet M., Colamonici O. R., Krolewski J. J. and Platanids L. C. (1997) The Vav proto-oncogene product (p95 vav) Interacts with the Tyk-2 protein tyrosine kinase. FEBS Lett. 403: 31-34
61. Machicle M., Mano H. and Todokoro K. (1995) Interleukin 3 and Erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 11: 619-625
62. Gulbins F., Schlottmann K., Brenner B., Linderkamp D., Long F. and Coggeshall K. M. (1995) Molecular analysis of Ras actuation by tyrosine phosphorylated Vav. Biochem. Biophys. Res. Commun. 217: 876-885
63. Boonefoy-Barard N., Munshi A., Yron I., Wu S., Collins T. L., Deckert M. et al. (1997) Vav: function and regulation in haemopoetic cell signalling. Stem Cells (Dayton) 14: 250-268
64. Crespo P., Schwebel K. L., Ostrom A. A., Crutkind J. S. and Bustelo X. R. (1997) Phospho-tyrosine-dependent activation of Rac-1 GDP-GTP exchange by the Vav proto-oncogene Product. Nature 385: 169-172
65. Lee J. M., Fournel M., Veilette A. and Branton P. F. (1996) Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-Cell lines. Oncogene 12: 253-263
66. Raab M., DaSilva A. J., Findell P. R. and Rudd C. E. (1997) Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR-ζ-CD3 ligation of interleukin-2. Immunity 6: 155-164
67. Stein P. H., Fraser J. D. and Weiss A. (1994) The cytoplasmic domain of CD3 is both necessary and sufficient for co-stimulation of interleukin-2 secretion and association with phosphatidylinositol-3-kinase. Mol. Cell. Biol. 14: 3392-3402
68. Mindino A. and Jenkins M. K. (1994) Surface proteins involved in T cell costimulation. J. Leukoc. Biol. 55: 805-815
69. Kariv I., Reddy M., Eichman C., Lyn S., Trunch A. and Sweet R. (1995) Deteminations of residues on CD28 involved in interaction with its counter receptors CD80(B7.1) and CD86(B7.2)-B70. Ninth International Congress of Immunology, San Francisco CA, abstract 285
70. fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein Grb-2 and T-cell specific protein tyrosine kinase ITK: implications for T cell co-stimulation Proc. Natl. Acad. Sci. USA 92: 8891-8895
71. Schneider H., Cai Y.-C., Prasal K. V. S., Shoelson S. E. and Rudd C. E. (1995) T cell antigen CD28 binds to the Grb-2-SOS complex regulator of p21-ras. Eur. J. Immunol. 25: 1044-1050
72. Macara I. G., Lounsbury K. M., Richards S. A., McKiernan C. and Bar-Sagi D. (1996) The Ras superfamily of GTPases. FASFB J. 10: 625-630
73. lck in antibody-triggered T cell signal transduction J. Biol. Chem. 269: 24095-24101
74. Hall C. G., Sancho J. and Terhorst C. (1993) Redistribution of T cell receptor ζ-mediated calcium mobilization in non-lymphoid cells. Science 261: 915-918
75. Sieh M., Batzer A., Schlessinger J. and Weiss A. (1994) Grb2 and phospholipase C-γ1 associate with a 36 to 38 kilodalton phosphotyrosine protein after T cell receptor stimulation. Mol. Cell. Biol. 14: 4435-4442
76. Burns D. J., Bloomenthal J., Lee M. H. and Bell R. M. (1990) Expression of the α, βII and γ protein kinase C isozymes in the baculovirus-insect cell expression system. Purification and characterisation of the individual isoforms. J. Biol. Chem. 265: 12044-12051
77. Loh C., Shaw K. T.-Y., Carew J., Viola J. P. B., Luo C., Perrino B. A. et al. (1996) Calcineurin hinds the transcriptional factor NF-AT1 and reversibly regulates its activity. J. Biol. Chem. 271: 10884-10891
78. Masuda E. S., Liu J., Imamura R . Imai S.-I., Arai K.-I. and Arai N. (1997) Translocation by a calcineurin-regulated inhibitory domain. Mol. Cell. Biol. 17: 2066-2075
79. Loh C., Carew J. A., Kim J., Hogan P. G. and Raq A. (1996) T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NF-AT1. Mol. Cell. Biol. 16: 3945-3954
80. Park J., Yaseen N. R., Hogan P. G., Rao A. and Sharma S. (1995) Phosphorylation of the transcription factor NF-AT-p inhibits its DNA binding activity in cyclosporin A-treated human B and T cells. J. Biol. Chem. 270: 20653-20659
81. Griffith J. P., Kim J. L., Kim F. F., Sintchak M. D., Thomson J. A., Fitzgibbon M. J. et al. (1995) X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP-12-FK506 complex. Cell 82: 507-522
82. Granelli-Piperno A. and Nolan P. (1991) Nuclear transcription factors that bind to elements of the IL-2 promoter induction requirements in primary human T cells. J. Immunol. 147: 2734-2739
83. Lyakh L., Ghuship P. and Rice N. R. (1997) Expression of NF-AT-family proteins in normal human T cells. Mol. Cell. Biol. 17: 2475-2484
84. Sun L. J., Peterson B. R. and Verdine G. L. (1997) Dual role of the nuclear factor of activated T cells insert region in DNA recognition and cooperative contacts to activator protein 1. Proc. Natl. Acad. Sci. USA 94: 4919-4924
85. Wolfe S. A., Zhou P., Dotsch V., Chen L., You A., Ho S. N. et al. (1997) Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NK-ATc. Nature 385: 172-176
86. Marshall M. (1995) Interactions between Ras and Raf: key regulatory proteins in cellular transformation. Mol. Reprod. Dev. 42: 493-499
87. Marais R., Light Y., Paterson H. F., Mason C. S. and Marshall C. J. (1997) Differential regulation of Rad-1, A-Raf and B-Raf by oncogenic Ras and tyrosine kinases. J. Biol. Chem. 272: 4378-4383
88. Genot E., Cleverley S., Henning S. and Cantrell D. (1996) Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J. 15: 3923-3933
89. Marais R., Wynne J. and Treismann R. (1993) The SRF accessory protein, Elk-1, contains a growth-factor-regulated transcriptional activation domain. Cell 73: 381-393
90. Whitmarsh A. J., Shore P., Sharrocks A. and Davis R. J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403-407
91. Derijard B., Hibi M., Wu L-H., Barrett T., Su B., Deng T. et al. (1994) JNK-1: a protein kinase stimulated by UV light and H-Ras that bind and phosphorylates the c-jun activation domain. Cell 76: 1025-1037
92. Shapiro V. S., Truitt K. E., Imhoden J. B. and Weiss A. (1997) CD28 mediates transcriptional upregulation of the interleukin-2 promoter through a composite element containing the CD28 RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17: 4051-4058
93. Kongen F., Grumant R.-J., Strasses A., Metcalf D., Li R., Tarlington D. et al. (1995) Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression. Clones Dev. 9: 1965-1977
94. Fos M., Schenk H., Hexel K., Boeverke P. A., Droege W. and Schulze-Osthoff K. (1995) IL-2 gene expression and NK-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14: 3731-340
95. Harhaj E. W., Maggirwar S. B., Good L. and Sin S.-C. (1996) CD28 mediates a potent co-stimulatory signal for a rapid degradation of I-κ-B-beta which is associated with accelerated activation of various NF-κ-B Rel heterodimers. Mol. Cell. Biol. 16: 6736-6743
96. Regnier C. H., Song H. Y., Gao X., Goecklel D. V., Cao Z. and Rothe M. (1997) Identification and characterisation of an I-κ-B kinase. Cell 90: 373-383
97. Traenckner E. B. and Bauerle P. A. (1995) Appearance of apparently ubiquitin-conjugated I-κ-B-alpha during its phosphorylation-induced degradation in intact cells. J. Cell. Sci. (Suppl. 19): 79-84
98. Schow S. and Joly A. (1996) Inhibition of NF-κ-B activation by the proteosome inhibitor N-acetyl-leucinyl-leucinyl-naleucinal. Mol. Biol. 7 (Suppl.): 180A
99. Rottenberg E. V. and Ward B. (1996) A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin-2 gene regulation. Proc. Natl. Acad. Sci. USA 93: 9358-9365
100. Theze J., Alzani P. M. and Berloglio J. (1996) Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol. Today 17: 481-486
101. Theze J. (1994) Cytokine receptors: a combinative family of molecules. Eur. Cytokine Netw. 5: 353-368
102. Algarte M., Lecine P., Costello R., Plet A., Olive D. and Imbert J. (1995) In vivo regulation of interleukin-2 receptor alpha gene transcription by the co-ordinated binding of constitutive and inducible factors in the human primary T cells. EMBO J. 14: 5060-5072
103. Ascherman D. P., Migene T.-S., Friedmann M. C. and Leonard W. J. (1997) Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. J. Biol. Chem. 272: 8704-8709
104. Lecine P., Algarte M., Rameil P., Beadling C., Bucher P., Mabholz M. et al. (1996) Elf-1 and Stat 5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene. Mol. Cell. Biol. 16: 6829-6840
105. John S., Marais R., Child R., Light Y. and Leonard W. J. (1996) Importance of low affinity Elf-1 sites in the regulation of lymphoid-specific inducible gene expression. J. Exp. Med. 183: 743-760
106. Ravichandran K. S., Igras V., Shoelson S. E., Fesik S. W. and Burakoff S. J. (1996) Evidence for a role for the phosphotyrosine-binding domain of She in interleukin 2 signaling. Proc. Natl. Acad. Sci. USA 93: 5275-5280
107. Abraham R. T. and Wiederrecht G. J. (1996) Immunopharmacology of rapamycin. Ann. Rev. Immunol. 14: 483-510
108. Schindler C. (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann. Rev. Biochem. 64: 621-651
109. Ellis H. M. and Horvitz H. R. (1986) Genetic control of programmed cell death in the nematode Caenorhahditis elegans. Cell 44: 817-829
110. Yuan J., Shaham S. and Ledoux S. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1-β converting enzyme. Cell 75: 641-652
111. Muzio M., Chinnaiyan A. M., Kischkel F. C., O'Rourke K., Shevehenko A., Ni J. et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 85: 817-827
112. Pronk G. J., Ramer K., Amiri P. and Williams L. T. (1996) Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271: 808-810
113. Hug H. and Saare T. F. (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291: 329-343
114. Keranen L. M., Dutil E. M. and Newton A. C. (1995) Protein kinase is regulated in vivo by three functionally distinct phosphorylations. Curr. Biol. 5: 1394-1404
115. Newton A. C. (1997) Regulation of protein kinase C by cofactors. In: Protein Kinase C. pp. 25-44, Parker P. J. and Dekker L. V. (eds). Chapman and Hall, New York
116. Newton A. C. (1995) Protein kinase C: structure, function and regulation. J. Biol. Chem. 270: 28495-28498
117. Pears C. J. and Goode N. T. (1997) PKC downregulation: signal or adaptation. In: Protein Kinase C, pp. 45-56. Parker P. J. and Dekker L. V. (eds). Chapman and Hall, New York
118. Kobayashi E., Nakano H., Morimoto M. and Tamaoki T. (1989) Calphostin C (UCN-1028C), a novel microbial compound is a highly potent and selective inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159: 548-553
119. Ruegg U. T. and Burgess G. M. (1989) Staurosporine K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Biochem. Sci. 10: 218-220
120. Birchall A. M., Bishop J., Bradshaw D., Cline A., Coffey J., Elliott L. H. et al. (1994) Ro 32-0432. a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J. Pharmacol. Exp. Ther. 268: 922-928
121. Elliott L. H., Wilkinson S. E., Sedgwick A. D., Hill C. H., Lawton G., Davis P. D. et al. (1990) K252a is a potent and selective inhibitor of phosphorylase kinase. Biochem. Biophys. Res. Commun. 171: 148-154
122. Nixon J. S., Wilkinson S. E., Davis P. D., Sedgwick A. D., Wadsworth J. and Westmacott D. (1991) Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases. Agents Actions 32: 188-193
123. Nakajima K., Kusafuka T., Takeda T., Fujitani Y., Nakae, K. and Hirano T. (1993) Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter. Mol. Cell. Biol. 13: 3027-3041
124. Meyer T., Regenass U., Fabbro D., Alteri E., Rosel J., Muller M. et al. (1989) A derivative of staurosporine shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumour activity. Int. J. Cancer 43: 851-856
125. Bit R. A., Davis P. D., Elliott L. H., Harris W., Hill C. H., Keech E. et al. (1993) Inhibitors of protein kinase C 3. Potent and highly selective bisidolylmaleimides by conformational restriction. J. Med. Chem. 36: 21-29
126. Alessi D. R. (1997) The protein kinase C inhibitors Ro 31-8220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1β (Rsk-2) and p70 S6 kinase. FEBS Lett. 402: 121-123
127. Nobrega A. F., Maldonado M. S. and Dos Reis G. A. (1986) Analysis of isolated and combined effects of calcium ionophore and phorbol ester on T lymphocyte activation. Clin. Exp. Immunol. 65: 559-569
128. Nixon J. S., Bishop J., Bradshaw D., Davis P. D., Hill C. H., Elliott L. H. et al. (1992) The design and biological properties of potent and selective inhibitors of PKC. Biochem. Soc. Trans. 20: 419-425
129. Cuvillier O., Pirianov G., Kleuser B., Vanek P. G., Coso O. A., Gutkin J. S. et al. (1996) Suppression of ceramide-mediated programed cell death by sphingosine-1-phosphate. Nature 381: 800-803
130. Mills G. B., May C., Hill M., Ebanks R., Roifman C., Mellors A. et al. (1989) Physiologic activation of protein kinase C limits IL-2 secretion. J. Immunol. 142: 1995-2003
131. Berry N., Ase K., Kishimoto A. and Nishizuka Y. (1990) Activation of resting T-cells requires prolonged stimulation of protein kinase C. Proc. Natl. Acad. Sci. USA 87: 2294-2298
132. Rossetti R. G., Seiler C. M., Laposala M. and Zurier R. B. (1995) Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids. Clin. Immunol. Immunopathol. 76: 220-224
133. Tsutsumi A., Kubo M., Fujii H., Freire-Moar J., Turck C. W. and Ransom J. T. (1993) Regulation of protein kinase C isoform proteins in phorbol ester stimulated Jurkat T lymphoma cells. J. Immunol. 150: 1746-54
134. Keenan C., Kelleher D. and Long A. (1995) Regulation of non-classical protein kinase C isoenzymes in a human T cell line. Eur. J. Immunol. 25: 13-17
135. Tsutsumi A., Kubo M., Fujii H., Freire-Moar J., Turck C. W. and Ransom J. T. (1993) Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells. J. Immunol. 150: 1746-1754
136. Baier G., Baier-Bitterlich G., Meiler N., Coggeshall K. M., Giampa L., Telford D. et al. (1994) Expression and biochemical characterization of human protein kinase C-θ. Eur. J. Biochem. 225: 195-203
137. Monks C. R. F., Kupfer H., Tamir I. and Kuper A. (1997) Selective modulation of protein kinase-θ during T-cell activation. Nature 385: 83-85
138. Wilkinson S. E. and Hallam T. J. (1994) Protein kinase C: is its pivotal role in cellular activation over-stated? Trends Pharmacol. Sci. 15: 53
139. Ahmed S., Kozma R., Monfries C., Hall C., Lim H. H., Smith P. et al. (1990) Human brain n-chimaerin cDNA encodes a novel phorbol ester receptor. Biochem. J. 272: 767-773
140. Ahmed S., Lee J., Best A., Monfries C. and Lim L. (1993) A novel functional target for tumor-promoting phorbol esters and lysophosphatidic acid. The p21rac-GTPase activating protein n-chimaerin. J. Biol. Chem. 268: 10709-10712
141. Merritt J. E., Sullivan J. A., Tse J., Wilkinson S. E. and Nixon J. S. (1997) Different sensitivities of neutrophil responses to a selective protein kinase C inhibitor. Ro 31-8425: redundancy in signal transduction. Cell. Signal. 9: 53-57
142. Nishizuka Y. 1984) The role of PKC in cell surface signal transduction and tumour promotion. Nature 308: 693-698
143. Berney S. M. and Atkinson T. P. (1995) Phosphatidylinositol hydrolysis in freshly isolated human T lymphocytes. J. Immunol. Methods 186: 71-77
144. Vassilopoulos D., Zurier R. B., Rossetti R. G. and Tsokos G. C. (1997) Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells. Clin. Immunol. Immunopathol. 83: 237-244
145. Szamel M., Retiermann B., Krebs B., Kurrle R. and Resch K. (1989) Activation signals in human lymphocytes. J. Immunol. 143: 2806-2813
146. Imboden J., Weyand C. and Govonzy J. (1987) Antigen recognition by a human T cell clone leads to increases in inositol triphosphate. J. Immunol. 138: 1322-1324
147. Fulop T. Jr., LeBlanc C., Lacombe G. and Dupuis G. (1995) Cellular distribution of protein kinase C isozymes in CD-3 mediated stimulation of human T-lymphocytes with aging. FEBS Lett 375: 69-74
148. Keenan C. Long A., Volkov Y. and Kelleher D. (1997) Protein kinase C isolypes θ, δ, η in human lymphocytes: Differential responses to signalling through the T-cell receptor and phorbol esters. Immunology 90: 557-563
149. Valge V. L., Wong J. G., Datlof B. M., Sinskey A. J. and Rao A. (1988) Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell 55: 101-102
150. Alkan S. S., Ritschmann S., Grigg D. and Erb P. (1993) Effects of a new protein kinase C inhibitor CGP 41251. on T cell functions: inhibition of activation, growth and target cell killing. Cell. Immunol. 150: 137-148
151. Bishop J., Greenham A. K., Lewis E. J. and Pole D. S. (1993) A Simple host-versus-graft model in the rat for the study of immunomodulatory drugs. Eur. J. Rheumatol. Inflamm. 13: 17-20
152. Heber-Katz E. (1994) Is experimental allergic encephalomyelitis a model of multiple sclerosis? In: Autoimmunity and Physiological Diseases, pp. 353 366, Coutinho A. and Kazatchkine M. D. (eds). Wiley-Liss Inc., New York
153. Lassman H., Vass K., Brunner C. and Seitelburger F. (1986) Characterization of inflammatory infiltrates in experimental allergic eneephalomyclilis. In: Progress in Neuropathology, vol. 6. pp. 33-36, Zimmerman H. M. (ed.). Raven Press, New York
154. Matsumoto Y. and Fujiwara M. (1987) Immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesions of EAE. J. Neurol. Sci. 77: 35-47
155. Grove D. S. and Mastro A. M. (1991) Differential activation and inhibition of lymphocyte proliferation by phorbol esters, mezerein, teleocidin and okadaic acid. Cancer Res. 51: 82-88
156. Szamel M., Ebel U., Uciechowski P., Kaever V. and Resch K. (1997) T cell antigen receptor dependent signalling in human lymphocytes: cholera toxin inhibits interleukin-receptor expression but not interleukin-2 synthesis by preventing activation of a protein kinase C isotype PKC-α. Biochim. Biophys. Ada 1356: 237-248
157. 2+ entry in Jurkat T cells. J. Biol. Chem. 272: 15426-15433
158. Gomez J., Martinez C., Garcia A. and Rebolla A. (1996) Association of phosphatidylinositol 3 kinase to protein kinase C zeta during interleukin-2 stimulation. Eur. J. Immunol. 26: 1781-1787
159. Iwata M., Ohoka Y., Kuwata T., Asada A., Zhao Y. and Mukai M. (1997) Regulation of thymocyte lineage commitment by the level of classical protein kinase C activity. J. Allergy Clin. Immunol. 99: S111
160. Freire Moar J., Tsutumu A. and Baya P. (1992) Use of an antisense RNA experimental system to explore the functions of the PKC isoenzymes in T cell function. Ann. NY Acad. Sci. 660: 288-290
161. Snyder J. T. II and Finn O. J. (1997) The role of protein kinase C-beta in T-lymphocyte activation and tolerance induction. J. Allergy Clin. Immunol. 99: S307
162. Muid R. E., Dale M. M., Davis P. D., Elliott L. H., Hill C. H., Kumar M. K. H. et al. (1991) A novel conformationally restricted protein kinase C inhibitor Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-recepter stimuli. FEBS Lett. 293: 169-172
163. Williams D. H., Hallam T. J. and Murray E. J. (1993) The role of protein kinase C in TCR-induced interleukin 2 secretion in human Jurkat T-cells. Biochem. Soc. Trans. 21: 383s
164. Williams D. H., Woodrow M., Cantrell D. A. and Murray E. J. (1995) Protein kinase C is not a downstream effector of p21ras in activated T cells. Eur. J. Immunol. 25: 42-47
165. Lindholm P. F., Tamami M., Makowski J. and Brady J. N. (1996) Human T-cell lymphotropic virus type I Tax-1 activation of NF-κ-B: involvement of the protein kinase C pathway. J. Virol. 70: 2525-2532
166. 2+-dependent signal transduclion pathways. J. Immunol. 155: 4685-4691
167. Baier-Bitterlich G., Uberall F., Bauer B., Fresser F., Wachter H. et al. (1996) Protein kinase C-θ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol. Cell. Biol. 16: 1842-1850
168. Meller N., Liu Y.-C., Collins T. L., Bonnefoy-Berard N., Baier G., Isakov N. et al. (1996) Direct interaction between PKC-θ and 14-3-3-tau in T cells: 14-3-3 overexpression results in inhibition of PKC-θ translocation and function. Mol. Cell. Biol. 16: 5782-5791